Results per Page:
Going beneath the skin: A closer look at serositis in cGVHD
From the Lee Lab, Clinical Research Division
Graft-versus-host disease outcomes improving for all Fred Hutch patients
From the Long-Term Follow-Up Research Group, Clinical Research Division
Age or HLA? Helping doctors pick the best blood stem cell donors for their patients
From Drs. Rohtesh Mehta and Stephanie Lee, Clinical Research Division
Hematopoietic stem cell transplantation outcomes are worse among non-Hispanic Blacks and lower-income groups
From the Lee Lab, Clinical Research Division
Blood and Marrow Transplant Reunion returns to Fred Hutch
Hundreds gather in Seattle to celebrate life, science and cancer survivorship
Breaking down barriers: Language and survival outcomes after transplant
From the Lee Lab, Clinical Research Division
Advances in blood disorders research continue despite COVID-19
Expanding use of CAR T-cell therapies, gene editing lead to insights at virtual annual meeting of the American Society of Hematology
Tip Sheet: Celebrate holidays safely, COVID-19 vaccines, challenges in HIV vaccine trials — and new insights on evolution
Summaries of recent Fred Hutch research findings and other news, plus resources for the American Society of Hematology’s annual meeting
Fred Hutch at ASH: Fauci fireside chat, latest on cell therapies, repairing immune function, COVID and clots — and more
The 62nd American Society of Hematology Annual Meeting and Exposition to be held virtually Dec. 5-8, 2020
Coronavirus outbreak puts 'open science' under a microscope
Quick release of data could stop an epidemic, disrupt how research is reported
Dr. Stephanie Lee honored as new Giuliani/Press Endowed Chair recipient
The honor will support Lee in perpetuity as she continues her research on blood stem cell transplantation and chronic GVHD
Poor quality of life in 1 in 5 caregivers of bone marrow transplant survivors
Largest-ever study IDs risk factors, paves way for interventions to help
3 big new leukemia research projects advance cutting-edge cell therapies, stem cell transplant
$20M renewal of 4-decade-long federal grant to Hutch scientists
What’s new in combatting chronic graft-vs.-host disease
Decades after the development of bone marrow transplant, researchers are making headway against one of its most common and deadly side effects